Author
Listed:
- Emmanuelle Thinon
(Imperial College London
Imperial College London
Present address: The Rockefeller University, 1230 York Avenue, New York, New York, USA)
- Remigiusz A. Serwa
(Imperial College London)
- Malgorzata Broncel
(Imperial College London)
- James A. Brannigan
(York Structural Biology Laboratory, University of York)
- Ute Brassat
(Imperial College London
Imperial College London
Present address: EUFETS GmbH, Vollmersbachstrasse 66, 55743 Idar-Oberstein, Germany)
- Megan H. Wright
(Imperial College London
Institute of Chemical Biology, Imperial College London
Present address: Department of Chemistry, TU München, Lichtenbergstrasse 4, D-85748 Garching, Germany)
- William P. Heal
(Imperial College London
Present address: Department of Chemistry, Kings College London, London SE1 1UL, UK)
- Anthony J. Wilkinson
(York Structural Biology Laboratory, University of York)
- David J. Mann
(Imperial College London
Institute of Chemical Biology, Imperial College London)
- Edward W. Tate
(Imperial College London
Institute of Chemical Biology, Imperial College London)
Abstract
Protein N-myristoylation is a ubiquitous co- and post-translational modification that has been implicated in the development and progression of a range of human diseases. Here, we report the global N-myristoylated proteome in human cells determined using quantitative chemical proteomics combined with potent and specific human N-myristoyltransferase (NMT) inhibition. Global quantification of N-myristoylation during normal growth or apoptosis allowed the identification of >100 N-myristoylated proteins, >95% of which are identified for the first time at endogenous levels. Furthermore, quantitative dose response for inhibition of N-myristoylation is determined for >70 substrates simultaneously across the proteome. Small-molecule inhibition through a conserved substrate-binding pocket is also demonstrated by solving the crystal structures of inhibitor-bound NMT1 and NMT2. The presented data substantially expand the known repertoire of co- and post-translational N-myristoylation in addition to validating tools for the pharmacological inhibition of NMT in living cells.
Suggested Citation
Emmanuelle Thinon & Remigiusz A. Serwa & Malgorzata Broncel & James A. Brannigan & Ute Brassat & Megan H. Wright & William P. Heal & Anthony J. Wilkinson & David J. Mann & Edward W. Tate, 2014.
"Global profiling of co- and post-translationally N-myristoylated proteomes in human cells,"
Nature Communications, Nature, vol. 5(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5919
DOI: 10.1038/ncomms5919
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5919. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.